Image showing sections of cerebral brain organoids derived from pluripotent stem cells.
via Agnieszka Rybak-Wolf, MDC/LifeTime
Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific breakthroughs and technologies over the next decade, to track, understand and treat human cells throughout an individual’s lifetime.
The LifeTime initiative, co-coordinated by the Max Delbrück Center of Molecular Medicine in the Helmholtz Association (MDC) in Berlin and the Institut Curie in Paris, has developed a strategy to advance personalized treatment for five major disease classes: cancer, neurological, infectious, chronic inflammatory and cardiovascular diseases. The aim is a new age of personalized, cell-based interceptive medicine for Europe with the potential of improved health outcomes and more cost-effective treatment, resulting in profoundly changing a person’s healthcare experience.
Earlier detection and more effective treatment of diseases
To form a functioning, healthy body, our cells follow developmental paths during which they acquire specific roles in tissues and organs. But when they deviate from their healthy course, they accumulate changes leading to disease which remain undetected until symptoms appear. At this point, medical treatment is often invasive, expensive and inefficient. However, now we have the technologies to capture the molecular makeup of individual cells and to detect the emergence of disease or therapy resistance much earlier.
Using breakthrough single-cell and imaging technologies in combination with artificial intelligence and personalized disease models will allow us to not only predict disease onset earlier, but also to select the most effective therapies for individual patients. Targeting disease-causing cells to intercept disorders before irreparable damage occurs will substantially improve the outlook for many patients and has the potential of saving billions of Euros of disease-related costs in Europe.
A detailed roadmap for implementing LifeTime
The perspective article “The LifeTime initiative and the future of cell-based interceptive medicine in Europe” and the LifeTime Strategic Research Agenda (SRA) explain how these technologies should be rapidly co-developed, transitioned into clinical settings and applied to the five major disease areas. Close interactions between European infrastructures, research institutions, hospitals and industry will be essential to generate, share and analyze LifeTime’s big medical data across European borders. The initiative’s vision advocates to benefit citizens all across Europe.
According to Professor Nikolaus Rajewsky, scientific director of the Berlin Institute for Medical System Biology at the Max Delbrück Center for Molecular Medicine and coordinator of the LifeTime Initiative, the LifeTime approach is the way into the future: “LifeTime has brought together scientists across fields – from biologists, to clinicians, data scientists, engineers, mathematicians, and physicists – to enable a much improved understanding of molecular mechanisms driving health and disease. Cell-based medicine will allow doctors to diagnose diseases earlier and intercept disorders before irreparable damage has occurred. LifeTime has a unique value proposition that promises to improve the European patient’s health.”
Dr. Geneviève Almouzni, director of research at CNRS, honorary director of the research center from Institut Curie in Paris and co-coordinator of the LifeTime Initiative believes that the future with LifeTime offers major social and economic impact: “By implementing interceptive, cell-based medicine we will be able to considerably improve treatment across many diseases. Patients all over the world will be able to lead longer, healthier lives. The economic impact could be tremendous with billions of Euros saved from productivity gains simply for cancer, and significantly shortened ICU stays for Covid-19. We hope EU leaders will realize we have to invest in the necessary research now.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cell-based interceptive medicine
- "Trojan Horse" Nanoparticles Kill Cancer Cells Without Drugson October 6, 2020 at 10:16 am
Scientists have created a “Trojan horse” that sneaks anticancer nanoparticles into cancer cells and causes them to self-destruct without any drugs. The res ...
- Cell Therapy Market and Technology Forecast, 2028 - ResearchAndMarkets.comon October 6, 2020 at 9:12 am
Market and Technology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global revenue of the cell therapy market is estimated to be around USD 6 billion in the year ...
- Novel CAR-T Cell Immunotherapy for Lymphoma Advances to Phase II Clinical Trialon October 6, 2020 at 4:32 am
A novel cancer therapy studied and developed at the Medical College of Wisconsin (MCW) with promising clinical outcomes is leading to a ...
- T-Cell-Based Vaccine Effective against Multiple Influenza Virus Strainson September 24, 2020 at 5:00 am
Madison describe a T-cell-based vaccine strategy that reportedly is effective against multiple strains of influenza virus. The experimental vaccine, administered through the nose, delivered ...
- New T-cell-based vaccine strategy provides broader protection against seasonal influenzaon September 24, 2020 at 2:15 am
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides ...
Go deeper with Google Headlines on:
Cell-based interceptive medicine
Go deeper with Bing News on:
- Lifetime Greenlights GIRL IN THE BASEMENTon October 6, 2020 at 1:25 pm
Under the Broader Focus initiative, Lifetime reunites with Elisabeth Röhm who is making her directorial debut with this film, and executive producer Manu Boyer who directed Röhm in last year's Family ...
- Lifetime Greenlights ‘Girl In the Basement’ Movie Starring Stefanie Scott, Judd Nelson & Joely Fisher; Elisabeth Röhm Directson October 6, 2020 at 9:13 am
Lifetime has lined up the next movie in its Ripped from the Headlines franchise, Girl in the Basement. The film, inspired by actual events of a young woman imprisoned in her family home, stars ...
- Lifetime Greenlights ‘Girl In The Basement’ Movie Starring Stefanie Scott, Judd Nelson & Joely Fisher; Elisabeth Rohm Directson October 6, 2020 at 9:10 am
Lifetime has lined up the next movie in its Ripped from the Headlines franchise, Girl in the Basement. The film, inspired by actual events of a young woman imprisoned in her family ...
- Curaleaf Announces Multi-Faceted, Month-Long Fundraising Initiative to Raise Awareness for Breast Canceron October 6, 2020 at 5:55 am
Ten Breast Cancer Awareness Organizations Selected to Benefit from Local Donation Programs, Nine States Launch Limited-Edition 'Pre-Rolls With a ...
- WCVB Channel 5 Launches Hearst Initiative, Matter of Fact Listening Tour, Advancing Conversations About Race & Justiceon October 5, 2020 at 3:02 pm
On Thursday, October 8 at 7 p.m. ET, the urgent conversation about race, equality and justice will be the focus of a live, multimedia, interactive forum across many of America’s most familiar media ...